10 mg Tirzepatide: Is This the Right Dose for You?

Why 10 mg is a meaningful decision point, not just another rung

The tirzepatide titration schedule exists to reduce side effects, not to delay results. The early doses (2.5 mg and 5 mg) are tolerability phases; their job is to let your digestive system adjust, and you can read more about how that process begins on our page covering the 1 mg tirzepatide starting point. By the time you reach 5 mg, most people's nausea has settled significantly. The move to 7.5 mg and then 10 mg is where therapeutic effect tends to deepen.

At 10 mg you are at a dose that, in clinical trials, produced meaningful weight loss for a substantial proportion of participants. The SURMOUNT-1 trial, published in the New England Journal of Medicine, tracked adults on tirzepatide over 72 weeks across the full dose range; the higher doses (10 mg and 15 mg) drove the strongest outcomes, with average body-weight reductions of around 20–21% at 15 mg. Results at 10 mg were close behind. That context matters when you and your prescriber are weighing up whether to stay here or move to 12.5 mg.

Not everyone needs to reach 15 mg. Some people lose weight well at 10 mg with fewer side effects than they experienced at lower doses. Others plateau and benefit from continuing upward. A practical habit worth building: once a week, note your weight, appetite level and any GI symptoms in your phone's notes app, a 30-second log that gives your prescriber solid evidence when it's time for a review.

Who tends to stay at 10 mg versus who moves on

The licensed approach, described in the Mounjaro SmPC on the Electronic Medicines Compendium, is to increase dose in approximately four-week steps, guided by tolerability and response. Staying at 10 mg makes sense when side effects are still present but manageable, when weight loss is continuing at a satisfying pace, or when a prescriber judges that the body needs more time before the next step.

Moving toward 12.5 mg is typically considered when weight loss has slowed or plateaued, tolerability is good, and the prescriber's review supports it. If you are thinking about the broader titration picture, our guide to Mounjaro dosing covers the full schedule in plain language. The decision is never yours to make alone, at nume, each dose increase requires a clinical re-review, not just a repeat order.

It is also worth knowing that starting at 2.5 mg and building gradually is not optional. Jumping to 10 mg from scratch carries a high risk of severe nausea, vomiting and other GI effects. The staged approach is there for a reason.

Side effects to watch at 10 mg, and when to act

The most common side effects of tirzepatide across all doses are gastrointestinal: nausea, loose stools, constipation, indigestion and fatigue. The NHS patient information for tirzepatide notes these are typically most noticeable after starting or stepping up, often easing within days to a couple of weeks. At 10 mg, some people experience a brief recurrence of nausea they thought had gone; this is normal and usually short-lived.

More serious but rare effects require urgent attention. Severe, persistent stomach pain (particularly if it spreads toward the back, with or without vomiting) needs same-day medical assessment because it can indicate pancreatitis. The MHRA's Drug Safety Update index contains the January 2026 communication on GLP-1 medicines and pancreatitis; anyone on tirzepatide should be aware of it. Gallbladder symptoms, signs of dehydration from persistent GI illness and allergic reactions are also reasons to seek help promptly rather than wait for your next review.

Women using oral contraceptives should add a non-oral method for the first four weeks of each dose increase, including the move to 10 mg, because tirzepatide can reduce pill absorption during that window. Discuss this with your prescriber if it applies to you.

Getting to 10 mg through a regulated service, and what review looks like

If you are considering starting tirzepatide privately, or have transferred from another provider at a lower dose, the route through a regulated pharmacy matters. Understanding what Mounjaro is and how it differs from other weight-loss medicines is a reasonable starting point. For context on pricing as doses increase (costs do rise at higher strengths) our page on the Eli Lilly UK price changes explains the background.

At nume, every dose step is treated as a fresh clinical assessment. Transfer patients provide evidence of their current treatment; dose increases are approved only once a prescriber is satisfied the evidence supports it. Our clinical team reviews every consultation the same day it is submitted, a named prescriber reads it, not an automated system. If you are curious about the people doing that reviewing, our lead prescriber's profile is public.

The weight-loss treatment overview on the site covers all options available, and if you have general questions before starting, the FAQs page is a useful first stop. When you are ready to check whether 10 mg (or a path toward it) is suitable for you, the place to begin is a free consultation.

Check your eligibility with a free consultation.